Charles River Laboratories International, Inc. (CRL) Financial Statements
Charles River Laboratories International, Inc. (CRL) reported trailing twelve-month revenue of $4.0B (down 0.7% year on year) and net income of -$238.5M as of 2026-06-30, according to EquiReason's reading of its SEC filings. Free cash flow over the same period: $370.6M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
- Market cap
- 16.5B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 4 Nov, in 11 days
Fiscal-year columns end in the month shown. The current fiscal year appears once its annual report is filed; until then TTM = the last four reported quarters, to Jun 26.
| Line | FY2010 Dec 10 | FY2011 Dec 11 | FY2012 Dec 12 | FY2013 Dec 13 | FY2014 Dec 14 | FY2015 Dec 15 | FY2016 Dec 16 | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.13 | 1.14 | 1.13 | 1.17 | 1.30 | 1.36 | 1.68 | 1.86 | 2.27 | 2.62 | 2.92 | 3.54 | 3.98 | 4.13 | 4.05 | 4.02 | 4.00 | |
| Gross profit | 0.64 | 0.67 | 0.65 | 0.67 | 0.74 | 0.80 | 0.92 | 0.99 | — | — | — | — | — | — | — | — | — | |
| Operating income | -0.30 | 0.17 | 0.17 | 0.15 | 0.18 | 0.21 | 0.24 | 0.29 | 0.33 | 0.35 | 0.43 | 0.59 | 0.65 | 0.62 | 0.23 | 0.03 | 0.09 | |
| Pre-tax income | -0.33 | 0.13 | 0.13 | 0.14 | 0.18 | 0.20 | 0.22 | 0.30 | 0.28 | 0.30 | 0.45 | 0.48 | 0.62 | 0.58 | 0.09 | -0.10 | -0.18 | |
| Income tax | 0.00 | 0.02 | 0.03 | 0.03 | 0.05 | 0.04 | 0.07 | 0.17 | 0.05 | 0.05 | 0.08 | 0.08 | 0.13 | 0.10 | 0.07 | 0.04 | 0.05 | |
| Net income | -0.34 | 0.11 | 0.10 | 0.10 | 0.13 | 0.15 | 0.15 | 0.12 | 0.23 | 0.25 | 0.36 | 0.39 | 0.49 | 0.47 | 0.02 | -0.14 | -0.24 | |
| Diluted EPS ($) | -5.38 | 2.14 | 2.01 | 2.12 | 2.66 | 3.13 | 3.23 | 2.54 | 4.62 | 5.07 | 7.20 | 7.60 | 9.48 | 9.22 | 0.20 | -2.91 | -4.79 | |
| Diluted shares (bn) | — | 0.051 | 0.048 | 0.048 | 0.048 | 0.048 | 0.048 | 0.049 | 0.049 | 0.050 | 0.051 | 0.051 | 0.051 | 0.051 | 0.052 | 0.050 | — |
USD billions · SEC XBRL
Charles River Laboratories International, Inc. — questions
- What is Charles River Laboratories International, Inc.'s revenue?
- $4.0B over the twelve months to 2026-06-30, down 0.7% year on year, from its 10-Q and 10-K filings.
- What is Charles River Laboratories International, Inc.'s net income?
- -$238.5M over the twelve months to 2026-06-30.
- What is Charles River Laboratories International, Inc.'s free cash flow?
- $370.6M over the twelve months to 2026-06-30.
- What are Charles River Laboratories International, Inc.'s diluted earnings per share?
- $-4.79 over the twelve months to 2026-06-30.
Every figure on this page comes from Charles River Laboratories International, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.